Concordia Healthcare Corp. T.CXR.R

CXR vs. VRX

[onward1]

Now that Valeant has done such a great job in squeezing shorts, will Concordia do as good of a job? The key difference between these two companies now may well be Mark Thompson has lost all credibility and Joe Papa is gaining it.

[wordless]

I'm curious - What has Mark Thompson done to make him lose all credability?  I believe he has delivered on everything he has said thus far?  Q1 was good.  If Q2 is good like promissed, then waht's the issue with credability at this stage?

[Sonicboooom]

The stock has lost 75% of its value and MT has done nothing to combat it.

[wallop13]

Wow. Not sure I agree. I'm looking at VRX's EBITDA & EPS numbers and I'm shocked that he just reaffirmed. By that standard CXR could very well reaffirm. VRX EPS is at 39% of guidance and ADJ EBITDA is at 43%. I now think MT could possibly reaffirm. No way in hell CXR comes in under 43% of guided EBITDA.

[wallop13]

Love VRX's earnings presentation PDF. Hope CXR can put something like that together.

[MustardTiger88]

Great reasoning there, considering it was VRX who was proved to be cooking the books.  I don't see how MT has lost credibility when compared to the mess that is VRX.

[onward1]

Mustard,  CXR stock price performance tells you MT lost all credibility. No one now believes him on this never-ending "strategic review". He could have been much more effective shopping the company but now the buyers clearly have walked away (after stringing him along for too long) and even the idiotic analysts don't trust anything he says about the debt, earnings, etc. 

[CNInvesting]

I don't think MT has lost all credibility, although I don't like him, but he clearly lacks some at least in the space of transparency and being fortright. He's always been very vague and I don't recall a single time where he talked of some aspect of the company in depth.  Valeant is doing better because they changed the CEO and actually are switching their business strategy